These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study. Castelo-Branco C, Palacios S, Vázquez F, Villero J, Ferrer J, Ascaso C, Balasch J. Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009 [Abstract] [Full Text] [Related]
5. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS, Women's Health Initiative Mammogram Density Study Investigators. J Natl Cancer Inst; 2005 Sep 21; 97(18):1366-76. PubMed ID: 16174858 [Abstract] [Full Text] [Related]
10. Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo. Lundström E, Hirschberg AL, Söderqvist G. Maturitas; 2011 Dec 21; 70(4):361-4. PubMed ID: 21958943 [Abstract] [Full Text] [Related]
13. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women. Georgiev DB, Manassiev NA. Medscape Womens Health; 2002 Dec 21; 7(4):1. PubMed ID: 12466733 [Abstract] [Full Text] [Related]
14. Less effect of intranasal than oral hormone therapy on factors associated with venous thrombosis risk in healthy postmenopausal women. Hemelaar M, Rosing J, Kenemans P, Thomassen MC, Braat DD, van der Mooren MJ. Arterioscler Thromb Vasc Biol; 2006 Jul 21; 26(7):1660-6. PubMed ID: 16645152 [Abstract] [Full Text] [Related]